SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Cipla Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
500087 INE059A01026 411.5542386 CIPLA 1.27 101,445.38 22.14 56.72 2
Quarters :
ParticularsDec 2025(Rs.Cr)Sep 2025(Rs.Cr)Jun 2025(Rs.Cr)
Gross Sales4256.934495.164501.66
Other Operating Income241.15730.56544.51
Other Income 416.70254.66271.07
Total Income4914.785480.385317.24
Total Expenditure 4021.253703.093421.72
PBIDT893.531777.291895.52
Interest 4.032.655.88
PBDT889.501774.641889.64
Depreciation153.33141.30145.69
Tax113.87412.22456.04
Fringe Benefit Tax0.000.000.00
Deferred Tax5.4210.59-15.22
Reported Profit After Tax616.881210.531303.13
Extra-ordinary Items -204.770.000.00
Adjusted Profit After Extra-ordinary item821.651210.531303.13
    
EPS (Unit Curr.)7.6414.9916.13
EPS (Adj) (Unit Curr.)7.6414.9916.13
Calculated EPS (Unit Curr.)7.6414.9916.13
Calculated EPS (Adj) (Unit Curr.)7.6414.9916.13
Calculated EPS (Ann.) (Unit Curr.)30.5559.9564.53
Calculated EPS (Adj) (Ann.) (Unit Curr.)30.5559.9564.53
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity161.55161.55161.55
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)20.9939.5442.11
PBDTM(%)20.9039.4841.98
PATM(%)14.4926.9328.95